MedTrace Logo

Role of Prophylactic Antibiotics in Preventing Pelvic Infection After Surgical Evacuation

NCT05040334 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2022-03-28

No results posted yet for this study

Summary

To determine the role of antibiotic prophylaxis in the surgical management of miscarriage.

Conditions

  • Antibiotics Causing Adverse Effects in Therapeutic Use

Interventions

DRUG

Group 1: Antibiotic receiving group

Group 1; receiving antibiotic prophylaxis; single dose of oral doxycycline (200 mg) tablet and metronidazole (500 mg) tablet 2 hours before the surgical evacuation Group B ;receiving placebo 2 hours before the surgical evacuation

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Marwa Mo Eid, Ass.prof. · Cairo University

  • Nihal Mo El-Demiry, lecturer · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-04-01
Completion
2022-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05040334 on ClinicalTrials.gov